Aurinia Pharmaceuticals
AUPH
AUPH
188 hedge funds and large institutions have $492M invested in Aurinia Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 59 increasing their positions, 62 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
188
Holders Change
-8
Holders Change %
-4.08%
% of All Funds
2.76%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
21
Increased
59
Reduced
62
Closed
26
Calls
$28.4M
Puts
$22.1M
Net Calls
+$6.26M
Net Calls Change
-$3.12M
Top Buyers
| 1 |
AC
1
Armistice Capital
New York
|
$85.7M |
| 2 |
2
Morgan Stanley
New York
|
$26.2M |
| 3 |
3
Schroder Investment Management Group
London,
United Kingdom
|
$9.35M |
| 4 |
4
Balyasny Asset Management
Chicago,
Illinois
|
$7.97M |
| 5 |
5
Goldman Sachs
New York
|
$18.4M |
